These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 32296726)

  • 1. Quantitative Benefit-Risk Models Used for Rotavirus Vaccination: A Systematic Review.
    Arlegui H; Nachbaur G; Praet N; Bégaud B
    Open Forum Infect Dis; 2020 Apr; 7(4):ofaa087. PubMed ID: 32296726
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Using Discretely Integrated Condition Event Simulation To Construct Quantitative Benefit-Risk Models: The Example of Rotavirus Vaccination in France.
    Arlegui H; Nachbaur G; Praet N; Bégaud B; Caro JJ
    Clin Ther; 2020 Oct; 42(10):1983-1991.e2. PubMed ID: 32988633
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Benefit Versus Risk Assessment of Rotavirus Vaccination in France: A Simulation and Modeling Analysis.
    Ledent E; Arlegui H; Buyse H; Basile P; Karkada N; Praet N; Nachbaur G
    BioDrugs; 2018 Apr; 32(2):139-152. PubMed ID: 29589230
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Post-Marketing Benefit-Risk Assessment of Rotavirus Vaccination in Japan: A Simulation and Modelling Analysis.
    Ledent E; Lieftucht A; Buyse H; Sugiyama K; Mckenna M; Holl K
    Drug Saf; 2016 Mar; 39(3):219-30. PubMed ID: 26748506
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Benefit-Risk Assessment of Vaccines. Part I: A Systematic Review to Identify and Describe Studies About Quantitative Benefit-Risk Models Applied to Vaccines.
    Arlegui H; Bollaerts K; Salvo F; Bauchau V; Nachbaur G; Bégaud B; Praet N
    Drug Saf; 2020 Nov; 43(11):1089-1104. PubMed ID: 32914292
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mortality reduction benefits and intussusception risks of rotavirus vaccination in 135 low-income and middle-income countries: a modelling analysis of current and alternative schedules.
    Clark A; Tate J; Parashar U; Jit M; Hasso-Agopsowicz M; Henschke N; Lopman B; Van Zandvoort K; Pecenka C; Fine P; Sanderson C
    Lancet Glob Health; 2019 Nov; 7(11):e1541-e1552. PubMed ID: 31607466
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluating the potential risks and benefits of infant rotavirus vaccination in England.
    Clark A; Jit M; Andrews N; Atchison C; Edmunds WJ; Sanderson C
    Vaccine; 2014 Jun; 32(29):3604-10. PubMed ID: 24814524
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Removing the age restrictions for rotavirus vaccination: a benefit-risk modeling analysis.
    Patel MM; Clark AD; Sanderson CF; Tate J; Parashar UD
    PLoS Med; 2012; 9(10):e1001330. PubMed ID: 23109915
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A benefit-risk analysis of rotavirus vaccination, France, 2015.
    Lamrani A; Tubert-Bitter P; Hill C; Escolano S
    Euro Surveill; 2017 Dec; 22(50):. PubMed ID: 29258644
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Projected Public Health Impact of a Universal Rotavirus Vaccination Program in France.
    Oluwaseun S; Cagnan L; Xausa I; Nachbar RB; Levy Bachelot L; Chen YH; Carias C
    Pediatr Infect Dis J; 2024 Jun; ():. PubMed ID: 38917026
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-effectiveness analysis of vaccination against rotavirus with RIX4414 in France.
    Standaert B; Parez N; Tehard B; Colin X; Detournay B
    Appl Health Econ Health Policy; 2008; 6(4):199-216. PubMed ID: 19382820
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of rotavirus vaccine on all-cause acute gastroenteritis and rotavirus hospitalizations in Israel: A nationwide analysis.
    Muhsen K; Haklai Z; Applbaum Y; Gordon ES; Shteiman A; Glatman-Freedman A; Leshem E
    Vaccine; 2020 Feb; 38(10):2406-2415. PubMed ID: 32029322
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness and cost-effectiveness of pediatric rotavirus vaccination in British Columbia: a model-based evaluation.
    Fisman DN; Chan CH; Lowcock E; Naus M; Lee V
    Vaccine; 2012 Dec; 30(52):7601-7. PubMed ID: 23107595
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potential intussusception risk versus health benefits from rotavirus vaccination in Latin America.
    Desai R; Parashar UD; Lopman B; de Oliveira LH; Clark AD; Sanderson CF; Tate JE; Matus CR; Andrus JK; Patel MM
    Clin Infect Dis; 2012 May; 54(10):1397-405. PubMed ID: 22431803
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of rotavirus vaccination on the burden of acute gastroenteritis in Nagoya city, Japan.
    Yoshikawa T; Matsuki T; Sato K; Mizuno M; Shibata M; Hasegawa S; Morita M; Iwasa M; Gopala K; Holl K
    Vaccine; 2018 Jan; 36(4):527-534. PubMed ID: 29248263
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rotavirus live, oral, pentavalent vaccine.
    Tom-Revzon C
    Clin Ther; 2007 Dec; 29(12):2724-37. PubMed ID: 18201590
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Population effectiveness of the pentavalent and monovalent rotavirus vaccines: a systematic review and meta-analysis of observational studies.
    Hungerford D; Smith K; Tucker A; Iturriza-Gómara M; Vivancos R; McLeonard C; A Cunliffe N; French N
    BMC Infect Dis; 2017 Aug; 17(1):569. PubMed ID: 28810833
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Success ofrotavirus vaccination in Finland, a register based study measuring impact beyond overall effectiveness.
    Solastie A; Leino T; Ollgren J
    Vaccine; 2020 May; 38(21):3766-3772. PubMed ID: 32280041
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of the rotavirus vaccine program across age groups in the United States: analysis of national claims data, 2001-2016.
    Baker JM; Dahl RM; Cubilo J; Parashar UD; Lopman BA
    BMC Infect Dis; 2019 Feb; 19(1):186. PubMed ID: 30795739
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Updated cost-effectiveness and risk-benefit analysis of two infant rotavirus vaccination strategies in a high-income, low-endemic setting.
    Bruijning-Verhagen P; van Dongen JAP; Verberk JDM; Pijnacker R; van Gaalen RD; Klinkenberg D; de Melker HE; Mangen MJ
    BMC Med; 2018 Sep; 16(1):168. PubMed ID: 30196794
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.